Free Trial

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity logo
$48.52 +2.27 (+4.91%)
(As of 11/21/2024 ET)

Ingevity - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
3

Based on 6 Wall Street analysts who have issued ratings for Ingevity in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 3 have given a hold rating, and 3 have given a buy rating for NGVT.

Consensus Price Target

$52.17
7.53% Upside
According to the 6 analysts' twelve-month price targets for Ingevity, the average price target is $52.17. The highest price target for NGVT is $62.00, while the lowest price target for NGVT is $40.00. The average price target represents a forecasted upside of 7.53% from the current price of $48.52.
Get the Latest News and Ratings for NGVT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ingevity and its competitors.

Sign Up

NGVT Analyst Ratings Over Time

TypeCurrent Forecast
11/23/23 to 11/22/24
1 Month Ago
10/24/23 to 10/23/24
3 Months Ago
8/25/23 to 8/24/24
1 Year Ago
11/23/22 to 11/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$52.17$51.00$51.33$50.00
Forecasted Upside7.53% Upside61.44% Upside33.54% Upside27.06% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold

NGVT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NGVT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ingevity Stock vs. The Competition

TypeIngevityBasic Materials CompaniesS&P 500
Consensus Rating Score
2.50
2.76
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside7.53% Upside120.11% Upside8.51% Upside
News Sentiment Rating
Very Positive News

See Recent NGVT News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/31/2024BMO Capital Markets
4 of 5 stars
 Boost TargetMarket Perform ➝ Market Perform$40.00 ➝ $47.00+16.48%
8/7/2024CJS Securities
4 of 5 stars
J. Tanwanteng
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$58.00+67.22%
8/5/2024Wells Fargo & Company
3 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$45.00 ➝ $40.00-2.91%
8/1/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$58.00 ➝ $50.00+19.16%
5/7/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$49.00 ➝ $56.00+4.26%
4/22/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$52.00 ➝ $62.00+39.51%
What This Post-Election Shift Means for Your Investments (Ad)

The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.

Click here now to watch the full briefing and prepare for what's next.

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:27 AM ET.


NGVT Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Ingevity is $52.17, with a high forecast of $62.00 and a low forecast of $40.00.

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NGVT shares.

According to analysts, Ingevity's stock has a predicted upside of 7.53% based on their 12-month stock forecasts.

Ingevity has been rated by research analysts at BMO Capital Markets in the past 90 days.

Analysts like Ingevity less than other "basic materials" companies. The consensus rating score for Ingevity is 2.50 while the average consensus rating score for "basic materials" companies is 2.76. Learn more on how NGVT compares to other companies.


This page (NYSE:NGVT) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners